The European Medicines Agency on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer
The European Medicines Agency on Tuesday said it would hold an extraordinary meeting on December 29 to consider emergency approval for a vaccine developed by Germany’s BioNTech and US giant Pfizer